18.91
0.93 (5.17%)
| Previous Close | 17.98 |
| Open | 18.56 |
| Volume | 5,854,593 |
| Avg. Volume (3M) | 3,231,260 |
| Market Cap | 5,392,507,904 |
| Price / Earnings (TTM) | 46.12 |
| Price / Earnings (Forward) | 19.16 |
| Price / Sales | 4.50 |
| Price / Book | 8.13 |
| 52 Weeks Range |
| Profit Margin | 2.24% |
| Operating Margin (TTM) | 27.86% |
| Diluted EPS (TTM) | 0.090 |
| Quarterly Revenue Growth (YOY) | 2.60% |
| Quarterly Earnings Growth (YOY) | -68.10% |
| Total Debt/Equity (MRQ) | 566.88% |
| Current Ratio (MRQ) | 2.46 |
| Operating Cash Flow (TTM) | 269.99 M |
| Levered Free Cash Flow (TTM) | 194.97 M |
| Return on Assets (TTM) | 7.01% |
| Return on Equity (TTM) | 5.88% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Diagnostics & Research (US) | Mixed | Bullish |
| Diagnostics & Research (Global) | Mixed | Bullish | |
| Stock | Sotera Health Company | Mixed | Bullish |
AIStockmoo Score
| Analyst Consensus | NA |
| Insider Activity | -4.0 |
| Price Volatility | -3.5 |
| Technical Moving Averages | -1.0 |
| Technical Oscillators | 4.0 |
| Average | -1.13 |
|
Sotera Health Co provides sterilization, analytical lab testing, and advisory services to help ensure that medical, pharmaceutical, and food products are safe for healthcare practitioners, patients, and consumers. The company operates in three reportable segments: Sterigenics, Nordion, and Nelson Labs. The Sterigenics segment, which generates maximum revenue, provides outsourced terminal sterilization and irradiation services for medical devices, pharmaceuticals, food safety, and other application markets using three core technologies: gamma irradiation, EO processing, and E-beam irradiation. Geographically, the company generates maximum revenue from the United States, followed by Canada, Europe, and other regions. |
|
| Sector | Healthcare |
| Industry | Diagnostics & Research |
| Investment Style | Small Core |
| % Held by Insiders | 2.51% |
| % Held by Institutions | 95.98% |
No data within this time range.
| Name | Avg. Buy ($) | Avg. Sell ($) | Net Quantity | Net Value ($) |
|---|---|---|---|---|
| LYONS JONATHAN M. | - | 17.98 | -11,316 | -203,462 |
| RUTZ MICHAEL P | - | 18.86 | -150,000 | -2,829,000 |
| Aggregate Net Quantity | -161,316 | |||
| Aggregate Net Value ($) | -3,032,462 | |||
| Aggregate Avg. Buy ($) | - | |||
| Aggregate Avg. Sell ($) | 18.42 | |||
| Name | Holder | Date | Type | Quantity | Price | Value ($) |
|---|---|---|---|---|---|---|
| RUTZ MICHAEL P | Officer | 07 Aug 2026 | Sell (-) | 150,000 | 18.86 | 2,829,000 |
| LYONS JONATHAN M. | Officer | 05 Aug 2026 | Disposed (-) | 11,316 | 17.98 | 203,462 |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |